Position in VNRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$34,872
+$30,140 QoQ
Shares Held
8,718
+2405.2% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 31 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VNRX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,237,465,109 across 101 Medical Devices names. VNRX ranks #59 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,165,231 | $222,304,264 | |
| 2 | PEN |
Penumbra Inc
|
620,943 | $203,899,052 | |
| 3 | SYK |
Stryker Corp
|
385,344 | $126,620,183 | |
| 4 | MDT |
Medtronic plc
|
1,337,911 | $115,929,987 | |
| 5 | BSX |
Boston Scientific Corp
|
1,576,640 | $98,934,159 | |
| 6 | MASI |
Masimo Corp
|
533,388 | $94,873,723 | |
| 7 | EW |
Edwards Lifesciences Corp
|
789,574 | $63,229,084 | |
| 8 | DXCM |
Dexcom Inc
|
834,087 | $52,380,663 |
All Filings in VNRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,872 | 8,718 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $4,732 | 348 | Shares | Defined | 2025-11-10 | |
| 2024-12-31 | $17,772 | 1,481 | Shares | Defined | 2025-02-12 | |
| 2022-03-31 | $21,009 | 349 | Shares | Defined | 2022-05-12 | |
| 2021-06-30 | $789 | 12 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $188,092 | 2,488 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $385,187 | 4,951 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $84,294 | 1,313 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $276,968 | 3,560 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $202,772 | 3,260 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||